ELIAS JOSEPH JABBOUR to Immunosuppressive Agents
This is a "connection" page, showing publications ELIAS JOSEPH JABBOUR has written about Immunosuppressive Agents.
Connection Strength
0.543
-
Comparison of thalidomide and lenalidomide as therapy for myelofibrosis. Blood. 2011 Jul 28; 118(4):899-902.
Score: 0.240
-
Addition of eltrombopag to immunosuppressive therapy in patients with newly diagnosed aplastic anemia. Cancer. 2018 11 01; 124(21):4192-4201.
Score: 0.100
-
Clinical outcomes in adult patients with aplastic anemia: A single institution experience. Am J Hematol. 2017 Dec; 92(12):1295-1302.
Score: 0.093
-
Adult acute myeloid leukemia. Mayo Clin Proc. 2006 Feb; 81(2):247-60.
Score: 0.041
-
New agents in myelodysplastic syndromes. Curr Hematol Rep. 2005 May; 4(3):191-9.
Score: 0.039
-
Final results of the phase II study of rabbit anti-thymocyte globulin, ciclosporin, methylprednisone, and granulocyte colony-stimulating factor in patients with aplastic anaemia and myelodysplastic syndrome. Br J Haematol. 2012 May; 157(3):312-20.
Score: 0.016
-
Current and future management options for myelodysplastic syndromes. Drugs. 2010 Jul 30; 70(11):1381-94.
Score: 0.014